Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 789 across all filing types
Latest filing 2021-08-20 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
2021年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2021 年半年度报告摘要' which translates to '2021 Half-Year Report Summary'. It contains detailed financial data such as revenue, net profit, earnings per share, and asset information for the half-year period. It also includes shareholder information and other company details relevant to the half-year period. The document length is 2755 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or a link to a report. Therefore, it is a comprehensive interim/quarterly report for a period shorter than a full fiscal year, fitting the definition of an Interim / Quarterly Report (IR). H1 2021
2021-08-20 Chinese
关于执行新会计准则并变更相关会计政策的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about the adoption of a new accounting standard and the related change in accounting policies. It details the reasons for the change, the impact on the company, and includes opinions from the board of directors, supervisory board, and independent directors. The document is relatively short (2132 characters) and does not contain actual financial statements or detailed financial data. It is a regulatory announcement about accounting policy changes rather than a full financial report or audit report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such announcements that do not fit other specific categories.
2021-08-20 Chinese
2021年第二次临时股东大会的通知公告（已取消）
AGM Information Classification · 95% confidence The document is a detailed notice about convening the 2021 second extraordinary general meeting of shareholders for 康泰医学系统（秦皇岛）股份有限公司. It includes information about the meeting date, voting procedures (both in-person and online), agenda items related to the issuance of convertible bonds, and instructions for shareholders on registration and proxy voting. The document is a formal announcement inviting shareholders to participate and vote on specific proposals at the meeting. It does not contain financial statements, audit results, or earnings data. It is not a transcript of a call or a report publication announcement. The content aligns with a notice for a shareholders meeting rather than the meeting materials or voting results. Therefore, the document fits best into the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings.
2021-08-20 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 11th meeting of the 3rd Board of Directors of 康泰医学系统（秦皇岛）股份有限公司. It includes approvals related to the issuance of convertible bonds, detailed terms of the bond issuance, authorization for the board to handle related matters, and other corporate governance decisions. The document is not a full financial report but rather a formal announcement of board decisions and approvals. It also references upcoming shareholder meetings for further approvals. The content focuses on board resolutions and management decisions rather than financial results or audit opinions. Therefore, the document fits best into the category of Board/Management Information (MANG). The document length (13,840 characters) and detailed content support this classification with high confidence.
2021-08-20 Chinese
关于向不特定对象发行可转换公司债券预案披露的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement (546 characters) regarding the company's plan to issue convertible bonds to unspecified investors. It mentions the board meeting where the proposal was approved and references the disclosure of the convertible bond issuance plan on a regulatory website. The document explicitly states it is a "提示性公告" (a prompt or indicative announcement) about the convertible bond issuance plan, not the plan itself or detailed financial data. It also clarifies that the issuance is subject to shareholder approval and regulatory consent. This fits the category of a Capital/Financing Update (CAP) as it relates to financing activities and capital structure changes. The document is not a full report, nor a regulatory filing or report publication announcement, but a direct update on financing plans.
2021-08-20 Chinese
康泰医学系统（秦皇岛）股份有限公司向不特定对象发行可转换公司债券预案
Capital/Financing Update Classification · 95% confidence The document is a detailed issuance proposal for convertible bonds by 康泰医学系统（秦皇岛）股份有限公司, including extensive financial data such as consolidated and parent company balance sheets and income statements for multiple years, as well as detailed terms of the bond issuance. It includes audited financial statements for 2018, 2019, and 2020, and unaudited data for the first half of 2021. The document is lengthy (15,000 characters) and contains substantive financial data and management discussion related to the bond issuance. This is not a brief announcement or a certification, but a comprehensive financial and operational report related to a capital raising activity. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2021-08-20 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.